Pfizer Profits Dip As It Ramps R&D Spending For New Drugs

Mixed Results For Lyme Disease Vaccine Hit Valneva Shares

Pfizer, Tris Pharma Settle For $41.5m In Texas ADHD Drug Case

Pfizer To Buy Metsera In $10b Deal 

Pfizer Reports Loss As COVID-19 Revenues Shrink

Pfizer Sets Sights On Elimination Of Blinding Disease Trachoma By 2030

Pfizer Offers To Sell Medicines At Cost To Poorest Countries

Pfizer Eyes COVID-19 Vaccine For All Variants Before 2023

BioNTech To Ship Mobile COVID-19 Vaccine Labs To Africa

Pfizer Projects Over $50bn Vaccine, Therapeutic Sale In 2022

Pfizer To Seek Green Light To Vaccinate Kids Five And Under

US Health Regulator Authorizes Pfizer’s COVID-19 Pill

U.S. Donates 2.5 Million Doses Of Pfizer COVID-19 Vaccines To Nigeria

Pfizer/Biontech Says Three Doses ‘Effective’ Against Omicron